These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Chalcones as Promising Lead Compounds on Cancer Therapy. León-González AJ; Acero N; Muñoz-Mingarro D; Navarro I; Martín-Cordero C Curr Med Chem; 2015; 22(30):3407-25. PubMed ID: 26219392 [TBL] [Abstract][Full Text] [Related]
10. Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA). Iwata S; Nishino T; Nagata N; Satomi Y; Nishino H; Shibata S Biol Pharm Bull; 1995 Dec; 18(12):1710-13. PubMed ID: 8787793 [TBL] [Abstract][Full Text] [Related]
11. The design and development of imidazothiazole-chalcone derivatives as potential anticancer drugs. Kamal A; Kashi Reddy M; Viswanath A Expert Opin Drug Discov; 2013 Mar; 8(3):289-304. PubMed ID: 23317445 [TBL] [Abstract][Full Text] [Related]
12. Secondary Metabolites from Acremonium Fungi: Diverse Structures and Bioactivities. Tian J; Lai D; Zhou L Mini Rev Med Chem; 2017; 17(7):603-632. PubMed ID: 27633747 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Chen M; Zhai L; Christensen SB; Theander TG; Kharazmi A Antimicrob Agents Chemother; 2001 Jul; 45(7):2023-9. PubMed ID: 11408218 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. Kumar SK; Hager E; Pettit C; Gurulingappa H; Davidson NE; Khan SR J Med Chem; 2003 Jul; 46(14):2813-5. PubMed ID: 12825923 [TBL] [Abstract][Full Text] [Related]
15. Efficient liquid-phase synthesis of 2'-hydroxychalcones. Stoyanov EV; Champavier Y; Simon A; Basly JP Bioorg Med Chem Lett; 2002 Oct; 12(19):2685-7. PubMed ID: 12217354 [TBL] [Abstract][Full Text] [Related]
16. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents. Atukuri D; S V; R S; L V; R P; M M R Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228 [TBL] [Abstract][Full Text] [Related]
17. Iminosugars and relatives as antiviral and potential anti-infective agents. Greimel P; Spreitz J; Stütz AE; Wrodnigg TM Curr Top Med Chem; 2003; 3(5):513-23. PubMed ID: 12570863 [TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties. Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256 [TBL] [Abstract][Full Text] [Related]
19. Antiobesity, antioxidant and cytotoxicity activities of newly synthesized chalcone derivatives and their metal complexes. El Sayed Aly MR; Abd El Razek Fodah HH; Saleh SY Eur J Med Chem; 2014 Apr; 76():517-30. PubMed ID: 24602794 [TBL] [Abstract][Full Text] [Related]
20. Synthetic chalcone derivatives as inhibitors of cathepsins K and B, and their cytotoxic evaluation. Ramalho SD; Bernades A; Demetrius G; Noda-Perez C; Vieira PC; Dos Santos CY; da Silva JA; de Moraes MO; Mousinho KC Chem Biodivers; 2013 Nov; 10(11):1999-2006. PubMed ID: 24243608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]